mifepristone has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gentenaar, M; Hunt, H; Kroon, J; Meijer, OC; Moll, TJA | 1 |
| Andrew, R; Bastin, ME; Gray, CD; Iredale, JP; Macfarlane, DP; Marshall, I; Preston, T; Raubenheimer, PJ; Walker, BR | 1 |
1 trial(s) available for mifepristone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver.
Topics: Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Metabolism; Enzyme Inhibitors; Fatty Acids, Nonesterified; Glycerol; Hormone Antagonists; Humans; Hydrocortisone; Indicator Dilution Techniques; Insulin; Liver; Magnetic Resonance Spectroscopy; Male; Metyrapone; Middle Aged; Mifepristone; Non-alcoholic Fatty Liver Disease; Receptors, Glucocorticoid; Scotland; Steroid 11-beta-Hydroxylase; Time Factors; Treatment Outcome | 2014 |
1 other study(ies) available for mifepristone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice.
Topics: Animals; Cholesterol; Diet, High-Fat; Female; Male; Mice; Mifepristone; Non-alcoholic Fatty Liver Disease; Receptors, Glucocorticoid | 2023 |